Vanguard Group’s Turnstone Biologics TSBX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $30.1K | Sell |
83,926
-431,161
| -84% | -$155K | ﹤0.01% | 4227 |
|
2025
Q1 | $211K | Sell |
515,087
-63,908
| -11% | -$26.2K | ﹤0.01% | 4064 |
|
2024
Q4 | $287K | Hold |
578,995
| – | – | ﹤0.01% | 4049 |
|
2024
Q3 | $323K | Hold |
578,995
| – | – | ﹤0.01% | 4063 |
|
2024
Q2 | $1.52M | Buy |
578,995
+209,319
| +57% | +$548K | ﹤0.01% | 3649 |
|
2024
Q1 | $969K | Buy |
369,676
+73,064
| +25% | +$191K | ﹤0.01% | 3826 |
|
2023
Q4 | $755K | Buy |
296,612
+188,003
| +173% | +$478K | ﹤0.01% | 3912 |
|
2023
Q3 | $428K | Buy |
+108,609
| New | +$428K | ﹤0.01% | 4103 |
|